Journals / Okmeydanı Tıp Dergisi / 2015 / Cilt: 31 - Sayı: 1

Cancer Cases in Five Year Period in the Secondary Health Care Institution of East Anatolia Region

Tümör Nüksünün İlk Bulgusu Aksiller ve İnguinal Dev Lenfadenopatilerde Cerrahi Tedavi Yaklaşımımız ve Cerrahinin Sağ Kalıma Etkisi

Pages
22–26
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although it's been said that there isn't any specific contribution to average 5 year survival it raises hope that there wasn't any recurrence during the follow-ups

📌 3 Key Takeaways

🎯
Objective & Hypothesis:After completion of surgical and oncological primary treatment of cancers, the effect of lymphadenectomy on patients' survival is controversial in patients with giant lymphadenopathy which is the first sign of cancer recurrence.
📊
Key Findings & Data:In this retrospective study we aimed to evaluate our treatment modalities and effect of surgery to survival in four patients with cancer relapse with giant inguinal and axillary lymphadenopathy.Material and Methods: The survey of the cases are evaluated via radiological and clinic datas after exicision of metastatic giant lympadenopathy and after termination of postoperative oncological therapy.Results: Due to giant lympadenopathy, region 1-2-3 axillary lymp node dissection to one patient and expanded inguinal lymph node dissection to three other patient were performed.
💡
Conclusion & Impact:Although it's been said that there isn't any specific contribution to average 5 year survival it raises hope that there wasn't any recurrence during the follow-ups
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

After completion of surgical and oncological primary treatment of cancers, the effect of lymphadenectomy on patients' survival is controversial in patients with giant lymphadenopathy which is the first sign of cancer recurrence. In this retrospective study we aimed to evaluate our treatment modalities and effect of surgery to survival in four patients with cancer relapse with giant inguinal and axillary lymphadenopathy.Material and Methods: The survey of the cases are evaluated via radiological and clinic datas after exicision of metastatic giant lympadenopathy and after termination of postoperative oncological therapy.Results: Due to giant lympadenopathy, region 1-2-3 axillary lymp node dissection to one patient and expanded inguinal lymph node dissection to three other patient were performed. The pathology of dissection material was matched with the primary tumor metastase. Oncologic therapy sessions were started in postoperative period. During 20 months follow-up of the cases there was not any recurrence or metastasis.Conclusion: In the cases that were evaluated after giant metastatic lymph node involvement, we assessed primary tumor type, clinical course as well as survival after surgical procedures that we performed for lymph node involvement. The survey is evaluated after clinical follow-up and primary tumor type with the surgery performed for lymph node invasion within the cases we evaluate after giant metastatic lymph node invasion. Although it's been said that there isn't any specific contribution to average 5 year survival it raises hope that there wasn't any recurrence during the follow-ups

Özet

Cerrahi ve onkolojik tedavisi tamamlanmış hastalarda, malign tümor nüksünün ilk bulgusu olarak karşımıza çıkabilen lenf nodu tutulumlarında yapılacak olan cerrahi tedavinin hastanın sağkalımına etkisi tartışmalıdır. Bu çalışmada, primer kanser tedavisi sonrasında nüksün ilk bulgusu olarak, aksiller ve inguinal bölgede tümör invazyonu olan dev lenfadenopati nedeniyle kliniğimize konsülte edilen dört hasta,retrospektif olarak incelenerek, tedavi yaklaşımlarımız ve yapılan prosedürlerin sağkalım oranına etkisini araştırılması amaçlanmıştır.Gereç ve Yöntemler: Olguların sağkalım süreleri, metastatik dev lenfadenopati eksizyonu ve postoperatif onkolojik tedavilerin tamamlanması sonrasında radyolojik yöntemler ve klinik veriler izlenerek değerlendirildi.Bulgular: Dev lenfadenopati nedeniyle 1 hastaya aksiller bölgeye, bölge 1,2,3 lenf nodu disseksiyonu, diğer 3 hastaya genişletilmiş inguinal lenf nodu disseksiyonu uygulandı. Disseksiyon materyali patoloji sonucu primer tümör metastazı ile uyumlu geldi. Postoperatif dönemde onkolojik tedavi süreçleri başlandı. Olguların yaklaşık 20 aylık toplam takip süreleri içerisinde nüks ve metastaza rastlanmadı.Sonuç: Dev metastatik lenf nodu tutuumu sonrası değerlendirdiğimiz olgularda, primer tümör tipi, klinik seyirler ile birlikte lenf nodu tutulumuna yönelik uyguladığımız cerrahi prosedürler sonrası sağkalım değerlendirilmiştir. 5 yıllık ortalama sağkalım için henüz net bir katkı sağlandığı söylenmesede devam etmekte olan mevcut takip süresince nüks izlenmemiş olması umut vericidir

🔖

Cite This Article

ÖZKAYA, Ö., TASASIZ, K., EGEMEN, O., AKAN, M., ÖZCAN, D. (2015). Cancer Cases in Five Year Period in the Secondary Health Care Institution of East Anatolia Region. Okmeydanı Tıp Dergisi, Cilt: 31 - Sayı: 1, 22–26. https://ajindex.com/articles/291757

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. McMasters KM, Chao C, Wong SL et al. Inter- val sentinel lymph nodes in melanoma. Arch Surg 2002;137(5):543-7; discussion 547-9. http://dx.doi.org/10.1001/archsurg.137.5.543 Denoix PF. Nomenclature classifi cation des cancers [in French]. Bull Inst Nat Hyg (Paris) 1952;7:743-8. International Union Against Cancer. TNM Classificati- on of Malignant Tumours. Geneva, Switzerland: Inter- national Union Against Cancer; 1968.
  2. Greene FL, Sobin LH. The staging of cancer: a retros- pective and prospective appraisal. CA Cancer J Clin 2008;58:180-90. http://dx.doi.org/10.3322/CA.2008.0001
  3. Naik AM, Fey J, Gemignani M, Heerdt A et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: A follow-up study of 4008 procedures. Ann Surg 2004;240:462-68. http://dx.doi.org/10.1097/01.sla.0000137130.23530.19
  4. Qadri SK, Hamdani NH, Shah P, Lone MI, Baba KM Profile of lymphadenopathy in Kashmir valley: a cyto- logical study. Asian Pacific Journal of Cancer Preven- tion: APJCP 2012;13(8):3621-362. http://dx.doi.org/10.7314/APJCP.2012.13.8.3621 Brunner M1, Veness MJ, Ch'ng S, Elliott M, Clark JR. Distant metastases from cutaneous squamous cell carcinoma--analysis of AJCC stage IV. Head Neck 2013;35(1):72-5. http://dx.doi.org/10.1002/hed.22913
  5. Homesley HD, Bundy BN, Sedlis A et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relativeto prognostic factors for survival. Am J Obstet Gynecol 1991;164(4):997-1003. http://dx.doi.org/10.1016/0002-9378(91)90573-A Clement BP. Disease of the peritoneum, In: Blaustein's Pathology of Female Genital Tract. Edited by Kurman RJ, Fifth Edition, Springer-Verlag 2002: 771-773.
  6. Altaras MM, Bernheim J, Zehavi T, et al. Papillary serous carcinoma of the peritoneum coexisting with or after en- dometrial carcinoma. Gynecol Oncol 2002;84:245-251. http://dx.doi.org/10.1006/gyno.2001.6492
  7. Roffers SD, Wu XC, Johnson CH, Correa CN. Inciden- ce of extraovarian primary cancers in the United States 1992-1997. Cancer Suppl 2003;97:2643-2647. http://dx.doi.org/10.1002/cncr.11346
  8. Halperin R, Zehavi S, Langer R et al Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papil- lary cancer. Int J Gynecol Cancer 2001;11(5):403-8. http://dx.doi.org/10.1046/j.1525-1438.2001.01027.x
  9. Tavassoli FA, Devilee P. WHO Histological Classifica- tion of Tumours of the ovary